17q12 Knowledge Basedeletion syndrome · static snapshot
All content was collected from public internet sources and processed with the help of AI/LLM software. This site is informative only — do not draw conclusions; verify with the original sources. Full disclaimer
Frequency / statistic kidney and urinary tract 1 supporting source confidence 97% novelty 60%

Patients with the 17q12del also developed end-stage kidney failure (ESKF) less frequently ( Supplementary Table S2 , P <

A source reports “97%” in the context of kidney: “Patients with the 17q12del also developed end-stage kidney failure (ESKF) less frequently ( Supplementary Table S2 , P < 0.001) and displayed a delayed progression to ESKF ( Supplementary Figure S3 a, P < 0.001) with ESKF-free survival of 97% (95% CI: 95-100) ”

How this was derived

Numbers are quoted verbatim from the source; check the source before quoting onward.

Generated 2026-11-13, last changed yesterday. Dedup key freq:97%. The engine re-checks this insight on every analysis run; if more sources agree, its corroboration and confidence go up and it reappears as “new”.

Evidence (1 quote)

Patients with the 17q12del also developed end-stage kidney failure (ESKF) less frequently ( Supplementary Table S2 , P < 0.001) and displayed a delayed progression to ESKF ( Supplementary Figure S3 a, P < 0.001) with ESKF-free survival of 97% (95% CI: 95-100) for the 17q12del versus 86% (95% CI: 79-94) for HNF1B variants at the age of 18 years.

Supporting documents (1)

DocumentSourcePublishedSeenRelevance
Renal and Extrarenal Phenotypes in Patients With HNF1B Variants and... pmc 2024-01-01 yesterday 1.00